retatrutide phase 2 nejm 2023 weight loss percent 48 weeks 🚨 BREAKING: Shows “Bariatric-Level” in 3 Trial New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most GLP-1 Medications for Weight Loss:

Regarding the serum GLP-1 and insulin levels, the levels of GLP-1 in T2DM and T2DM + sham group were significantly lower than NC group, compared with the T2DM + sham group, GLP-1 levels increased dramatically in T2DM + RYGB and T2DM + EX-4 groups (Figure 6H)

[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Balasse E.O., Fry F

Guidelines provided by KDIGO similarly recommend SGLT2i for people with an eGFR of 30 ml/min/1.73 m 2 due to the vascular and renal benefit, despite its modest effect on glucose control [2]

The medication is the tool

References: What Americans Think of Ozempic And Other Weight Loss Drugs

Ganamurali et al